Implementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need? [electronic resource]
- The Journal of infectious diseases 10 2017
- 787-789 p. digital
Publication Type: Journal Article
1537-6613
10.1093/infdis/jix351 doi
Acquired Immunodeficiency Syndrome--economics Continuity of Patient Care--economics Cost-Benefit Analysis Female HIV--physiology HIV Infections--economics Humans Male United States--epidemiology